Suppr超能文献

Oncohistone 突变和 PTM 串扰对 NatD N 端乙酰化活性的影响。

Effects of Oncohistone Mutations and PTM Crosstalk on the N-Terminal Acetylation Activities of NatD.

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.

出版信息

ACS Chem Biol. 2023 Apr 21;18(4):693-700. doi: 10.1021/acschembio.1c00840. Epub 2022 Jan 19.

Abstract

Acetylation at the α-N-terminus (Nα) is the most abundant modification detected on histone H4 and H2A, which is catalyzed by N-terminal acetyltransferase D (NatD or NAA40). Histone H4 and H2A contain an identical N-terminal SGRGK sequence that is enriched with post-translational modifications (PTMs) and frequently occurred oncogenic mutations known as "oncohistone" mutations. However, there is a lack of information on how oncohistone mutations and other PTMs affect NatD-catalyzed acetylation. Herein, we determined how the local chemical environment on the N-terminal SGRGK sequence impacts NatD-catalyzed Nα-acetylation on histone H4/H2A. Our studies indicate that all oncohistone mutations at SGRG suppressed NatD-catalyzed acetylation. Meanwhile, H4 Ser1 phosphorylation and Arg3 methylation negatively impact the NatD-mediated acetylation, but the Lys5 acetylation only has a marginal effect. This work reveals the impacts of oncohistone mutations on NatD activity and unravels the crosstalk between NatD and PTMs, implying potential regulatory mechanism of NatD and highlighting different avenues to interrogate the NatD-mediated pathway in the future.

摘要

Nα 端乙酰化是组蛋白 H4 和 H2A 上检测到的最丰富的修饰,由 N 端乙酰转移酶 D(NatD 或 NAA40)催化。组蛋白 H4 和 H2A 含有相同的 N 端 SGRGK 序列,富含翻译后修饰(PTM)和频繁发生的致癌突变,称为“癌组蛋白”突变。然而,关于癌组蛋白突变和其他 PTM 如何影响 NatD 催化的乙酰化的信息还很缺乏。本文我们确定了 N 端 SGRGK 序列上的局部化学环境如何影响 NatD 催化的组蛋白 H4/H2A 的 Nα-乙酰化。我们的研究表明,SGRG 上的所有癌组蛋白突变都抑制了 NatD 催化的乙酰化。同时,H4 Ser1 磷酸化和 Arg3 甲基化负向影响 NatD 介导的乙酰化,但 Lys5 乙酰化只有微小的影响。这项工作揭示了癌组蛋白突变对 NatD 活性的影响,并揭示了 NatD 和 PTM 之间的串扰,暗示了 NatD 的潜在调节机制,并突出了未来研究 NatD 介导途径的不同途径。

相似文献

9
Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.新型双底物蛋白 N-端乙酰转移酶 D 抑制剂
J Med Chem. 2021 Jun 24;64(12):8263-8271. doi: 10.1021/acs.jmedchem.1c00141. Epub 2021 Jun 10.

本文引用的文献

1
Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.新型双底物蛋白 N-端乙酰转移酶 D 抑制剂
J Med Chem. 2021 Jun 24;64(12):8263-8271. doi: 10.1021/acs.jmedchem.1c00141. Epub 2021 Jun 10.
3
Short H2A histone variants are expressed in cancer.短型 H2A 组蛋白变体在癌症中表达。
Nat Commun. 2021 Jan 20;12(1):490. doi: 10.1038/s41467-020-20707-x.
9
A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.组蛋白 H2B 突变代表了一类新的致癌驱动因素。
Cancer Discov. 2019 Oct;9(10):1438-1451. doi: 10.1158/2159-8290.CD-19-0393. Epub 2019 Jul 23.
10

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验